Page last updated: 2024-09-03

y 27632 and 1-(3,4-dimethoxyphenethyl)-4-(3-phenylpropyl)piperazine dihydrochloride

y 27632 has been researched along with 1-(3,4-dimethoxyphenethyl)-4-(3-phenylpropyl)piperazine dihydrochloride in 1 studies

Compound Research Comparison

Studies
(y 27632)
Trials
(y 27632)
Recent Studies (post-2010)
(y 27632)
Studies
(1-(3,4-dimethoxyphenethyl)-4-(3-phenylpropyl)piperazine dihydrochloride)
Trials
(1-(3,4-dimethoxyphenethyl)-4-(3-phenylpropyl)piperazine dihydrochloride)
Recent Studies (post-2010) (1-(3,4-dimethoxyphenethyl)-4-(3-phenylpropyl)piperazine dihydrochloride)
1,9243891113241

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hashimoto, K; Ishima, T; Itoh, K; Minase, T1

Other Studies

1 other study(ies) available for y 27632 and 1-(3,4-dimethoxyphenethyl)-4-(3-phenylpropyl)piperazine dihydrochloride

ArticleYear
Potentiation of nerve growth factor-induced neurite outgrowth by the ROCK inhibitor Y-27632: a possible role of IP₃ receptors.
    European journal of pharmacology, 2010, Dec-01, Volume: 648, Issue:1-3

    Topics: Amides; Animals; Drug Synergism; Inositol 1,4,5-Trisphosphate Receptors; MAP Kinase Signaling System; Nerve Growth Factor; Neurites; PC12 Cells; Piperazines; Protein Kinase Inhibitors; Pyridines; Rats; Receptor, trkA; rho GTP-Binding Proteins; rho-Associated Kinases

2010